The usefulness of biomarkers such as Neutrophil Gelatinase Associated Lipocalin (NAGL), interleukin-18, kidney injury molecule-1, and L-FABP have been studied in patients with cirrhosis [10]. The gene discussed is LCN2; the disease is Cirrhosis.